Nexien BioPharma, Inc. engages in the development and commercialization of Food and Drug Administration-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company is headquartered in Glendale, Colorado. The company went IPO on 2001-07-11. The firm is focused on developing and commercializing United States Food and Drug Administration (FDA)-compliant cannabinoid pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders and medical conditions. The firm is utilizing cannabinoids as the active pharmaceutical ingredients to develop synthetic pharmaceuticals in strict accordance with the U.S. FDA pre-clinical and clinical pathways. Its flagship research and development programs are focused on advancing formulations that have the potential to improve the treatment outcomes of certain convulsive disorders and neuromuscular disorders, which includes the treatment of myotonic dystrophy. The firm's wholly owned subsidiaries include Intiva BioPharma Inc., NexN Inc. (NexN) and NexDM Inc.
NXEN stock price ended at $0 on Monday, after rising NaN%
On the latest trading day Jun 01, 2026, the stock price of NXEN rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 19.4K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 500 shares were traded, amounting to a market value of approximately --.
NXEN Technical Signals
Technical Signals Summary
Buy Signals 2
Neutral Signals 3
Sell Signals 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
NXEN currently exhibits 2 buy signals and 2 sell signals. The stock has been in an uptrend since 12:00 AM, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for NXEN
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for NXEN. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to NXEN?
According to technical analysis, Nexien Biopharma Inc has an aggregate signal of Neutral. Nexien Biopharma Inc has 2 Buy signals, 3 Neutral Signals and 2 sell signals.
What are the Fibonacci retracement levels for NXEN?
The Fibonacci retracement level for Nexien Biopharma Inc is between 0% and 23.6%
What is the RSI for Nexien Biopharma Inc?
The RSI for Nexien Biopharma Inc is currently 15.00, indicating a oversold condition
What is Nexien Biopharma Inc price for the next 12 months?
Nexien Biopharma Inc NXEN price for the next 12 months is estimated at $0.
How high is Nexien Biopharma Inc expected to go?
According to wall street analysts, Nexien Biopharma Inc is expected to reach a high forecast of $0.